https://www.fool.com/earnings/call-transcripts/2024/02/08/dexcom-dxcm-q4-2023-earnings-call-transcript/?source=iedfolrf0000001
Feb 08, 2024 - DXCM earnings call for the period ending December 31, 2023.
0
fool:-3920879643932753609
0
https://www.fool.com/investing/2024/02/10/2-no-brainer-healthcare-stocks-to-buy-right-now/?source=iedfolrf0000001
Feb 10, 2024 - Companies in the healthcare industry tend to generate returns in a wide range of market environments.
0
fool:9127057496646365978
0
https://www.zacks.com/stock/news/2192251/cvs-health-s-cvs-digital-focus-aids-growth-macro-issues-ail?cid=CS-ZC-FT-analyst_blog|zer_report_update-2192251
Dec 01, 2023 - CVS Health's (CVS) Health Care Benefits segment demonstrates value to consumers and clients by successfully managing drug cost trends and bringing innovative clinical solutions to the market.
zc:-457170168754122629
0
https://www.zacks.com/stock/news/2192709/thermo-fisher-tmo-advances-health-equity-via-new-partnership?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2192709
Dec 04, 2023 - Thermo Fisher (TMO) announces a collaboration with Project HOPE to improve health outcomes by enabling expanded access to HIV testing and support services in Nigeria.
zc:-6189043047275391729
0
https://www.zacks.com/stock/news/2193456/integra-gains-from-new-product-launches-mounting-costs-ail?cid=CS-ZC-FT-analyst_blog|zer_report_update-2193456
Dec 05, 2023 - Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America.
zc:7386248100454959900
0
https://www.zacks.com/stock/news/2193656/why-you-should-retain-unitedhealth-group-unh-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2193656
Dec 05, 2023 - Growing membership, expanding government business, strategic acquisitions, improving operating margin and solid growth outlook poise UnitedHealth Group (UNH) well for growth.
zc:-745285338238927207
0
https://www.zacks.com/stock/news/2194242/3-reasons-to-retain-amn-healthcare-amn-stock-in-your-portfolio?cid=CS-ZC-FT-analyst_blog|rank_focused-2194242
Dec 06, 2023 - Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
zc:5014851705253747314
0
https://www.zacks.com/stock/news/2194719/globus-medical-gmed-gains-from-nuvasive-deal-macro-woes-stay?cid=CS-ZC-FT-analyst_blog|zer_report_update-2194719
Dec 07, 2023 - Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
zc:6971902992246997809
0
https://www.zacks.com/stock/news/2196236/why-you-should-retain-merit-medical-mmsi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196236
Dec 11, 2023 - Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
zc:5123529144280873345
0
https://www.zacks.com/stock/news/2196004/walgreens-wba-alliancerx-pharmacy-will-now-distribute-xdemvy?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196004
Dec 11, 2023 - Walgreens' (WBA) subsidiary, AllianceRx Walgreens Pharmacy, is one of the four specialty pharmacies selected to distribute XDEMVY.
zc:-4086703999000168526
0